Identification of TNF-α and MMP-9 as Potential Baseline Predictive Serum Markers of Sunitinib Activity in Patients With Renal Cell Carcinoma Using a Human Cytokine Array

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6605409
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Serum MMP-2 as a Potential Predictive Marker for Papillary Thyroid Carcinoma

PLoS ONE
Multidisciplinary
2018English

Inhibition of MMP-9 Using a Pyrrole-Imidazole Polyamide Reduces Cell Invasion in Renal Cell Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2013English

Sunitinib Causes Macrocytosis in Patients With Advanced Renal Cell Carcinoma

Current Oncology
Oncology
2010English

Cox-2 Inhibition Enhances the Activity of Sunitinib in Human Renal Cell Carcinoma Xenografts

British Journal of Cancer
Cancer ResearchOncology
2013English

A Phase 2 Trial of Sunitinib in Patients With Advanced Non–clear Cell Renal Cell Carcinoma

European Urology
Urology
2012English

Tumor Endothelial ELTD1 as a Predictive Marker for Treatment of Renal Cancer Patients With Sunitinib

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Sunitinib-Associated Hypertension and Neutropenia as Efficacy Biomarkers in Metastatic Renal Cell Carcinoma Patients

British Journal of Cancer
Cancer ResearchOncology
2015English

Hypertension as Predictor of Sunitinib Treatment Outcome in Metastatic Renal Cell Carcinoma

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2011English

Correlation of C-Met Expression and Outcome in Patients With Renal Cell Carcinoma Treated With Sunitinib

Clinical Genitourinary Cancer
OncologyUrology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy